Immunohistochemical studies of HB-EGF expression in breast carcinoma tumor cells have found no [31] or an inverse correlation [32] to tumor progression parameters, whereas our study indicates a positive contribution of TAM-derived HB-EGF production in the primary tumor to invasive mammary carcinoma progression. This evidence concerns the gene HBEGF and invasive breast carcinoma.